Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Ypsomed Holding AG
YPSNYpsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland. Address: Brunnmattstrasse 6, Burgdorf, Switzerland, 3401
Analytics
Precio Objetivo de WallStreet
157.61 CHFRelación P/E
71.4286Rentabilidad por dividendo
0.27 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave YPSN
Análisis de dividendos YPSN
Aumento del dividendo durante 5 años
-53 %Crecimiento continuo
1 AñoRatio de pago medio en 5 años
36 %Tendencia del payout YPSN
Valoración de la acción YPSN
Finanzas YPSN
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |